|
HY-124543-25mg
|
MedChemexpress LLC
|
MRS-1191 [CAS 185222-90-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-124543-5mg
|
MedChemexpress LLC
|
MRS-1191 [CAS 185222-90-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-124543-50mg
|
MedChemexpress LLC
|
MRS-1191 [CAS 185222-90-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-124543-1mL
|
MedChemexpress LLC
|
MRS-1191 [CAS 185222-90-6] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103190-10mg
|
MedChemexpress LLC
|
MRS1220 [CAS 183721-15-5]
|
|
Cancer-programmed cell death
|
|
|
HY-103190-100mg
|
MedChemexpress LLC
|
MRS1220 [CAS 183721-15-5]
|
|
Cancer-programmed cell death
|
|
|
HY-103190-25mg
|
MedChemexpress LLC
|
MRS1220 [CAS 183721-15-5]
|
|
Cancer-programmed cell death
|
|
|
HY-103190-5mg
|
MedChemexpress LLC
|
MRS1220 [CAS 183721-15-5]
|
|
Cancer-programmed cell death
|
|
|
HY-103190-50mg
|
MedChemexpress LLC
|
MRS1220 [CAS 183721-15-5]
|
|
Cancer-programmed cell death
|
|
|
HY-103174-10mg
|
MedChemexpress LLC
|
MRS1334 [CAS 192053-05-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103174-5mg
|
MedChemexpress LLC
|
MRS1334 [CAS 192053-05-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103186-10mg
|
MedChemexpress LLC
|
MRS-1706 [CAS 264622-53-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-103186-100mg
|
MedChemexpress LLC
|
MRS-1706 [CAS 264622-53-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-103186-5mg
|
MedChemexpress LLC
|
MRS-1706 [CAS 264622-53-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-103186-50mg
|
MedChemexpress LLC
|
MRS-1706 [CAS 264622-53-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-103186-1mL
|
MedChemexpress LLC
|
MRS-1706 [CAS 264622-53-9] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-103310-10mg
|
MedChemexpress LLC
|
MRS1845 [CAS 544478-19-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103310-100mg
|
MedChemexpress LLC
|
MRS1845 [CAS 544478-19-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103310-25mg
|
MedChemexpress LLC
|
MRS1845 [CAS 544478-19-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103310-5mg
|
MedChemexpress LLC
|
MRS1845 [CAS 544478-19-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103310-50mg
|
MedChemexpress LLC
|
MRS1845 [CAS 544478-19-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103310-1mL
|
MedChemexpress LLC
|
MRS1845 [CAS 544478-19-5] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-101308A-5mg
|
MedChemexpress LLC
|
MRS2179 (tetrasodium hydrate)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-108657A-1mg
|
MedChemexpress LLC
|
MRS2279 (diammonium) [CAS 2387505-47-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-136501-5mg
|
MedChemexpress LLC
|
MRS2395 [CAS 491611-55-3]
|
|
Neuroscience-Neuromodulation
|
|
